British Prime Minister Sir Keir Starmer got a taste of Bollywood when he visited Mumbai's Yash Raj Studios. Rani Mukerji dutifully played the host even as her husband YRF Chairman Aditya Chopra ...

Dhanashree Verma faces criticism on 'Rise and Fall' from Manisha Rani. Rani calls Verma's Red Room statements baseless and influenced. This comes after cricketer Yuzvendra Chahal denied cheating ...

MUMBAI: Plans to restart Van Rani (Queen of the Jungle), the mini train at the Sanjay Gandhi National Park (SGNP) and a popular tourist attraction, are falling prey to petty thieves and the weather.

Sunny Sanskari Ki Tulsi Kumari box office collection day 4: The Varun Dhawan and Janhvi Kapoor film is a spiritual successor to the Dulhania films. Sunny Sanskari Ki Tulsi Kumari box office collection ...

Varun Dhawan, Janhvi Kapoor, Rohit Saraf and Sanya Malhotra led Sunny Sanskari Ki Tulsi Kumari has concluded its opening weekend. The romantic-comedy drama is enjoying good buzz despite an intense box ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Actress Rani Mukerji met United Kingdom Prime Minister Keir Starmer on Wednesday, October 8, during his visit to Yash Raj Films (YRF) studio in Mumbai's Andheri suburb, a key hub of Bollywood ...

For decades, Sharda Sinha’s voice has been inseparable from the spirit of Chhath Puja. Born in Bihar in 1952, she elevated Bhojpuri and Maithili folk music to national recognition, becoming the ...

Veteran actor Pankaj Dheer, famous for playing Karna in 'Mahabharat', has sadly passed away at 68 after battling cancer. He was known for his strong acting in TV and movies. His son Nikitin Dheer and ...

Pankaj Dheer played the role of Karna in Mahabharat. Actor Pankaj Dheer, best known for playing the iconic role of Karna in BR Chopra's 1988 TV series Mahabharat, died on Wednesday. He was 68. Pankaj ...

(Reuters) -Rani Therapeutics on Friday announced a licensing deal to develop and sell an oral version of Chugai Pharmaceutical's experimental antibody, with options to expand to five additional drugs, ...